Company: Schlesinger Group

Compensation: $100

Link to Sign Up: LINK


Good Afternoon, Alll! Schlesinger Group is looking for people diagnosed with Type II Diabetes, who are currently taking Rybelsus® (semaglutide tablet) for treatment, to join an upcoming market research study on Diabetes. This study will be taking place via phone interviews with computer/webcam, starting on Monday (September 7th). We do want to preface that we will only confirm you after you have been fully screened and we receive picture proof of your medication.

If qualified, and asked to participate, you will receive $100 for your time and opinions!

If interested please click the link below, and complete a short questionnaire, to see if you qualify: